Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients

Erbilgin et al. (2026) used Genomize-SEQ to analyze targeted sequencing data from pediatric leukemia patients, finding that a key gene deletion (IKZF1) became more frequent at relapse — pointing to its role in treatment resistance rather than early disease prediction.